Sunday, December 29, 2024
HomeTagsAntigen

antigen

Avacta Announces AffiDX® SARS-CoV-2 Antigen Lateral Flow Test Receives CE Mark for Consumer Self-Testing

Avacta Group plc (AIM: AVCT), a clinical stage biopharmaceutical company developing innovative cancer therapies and powerful diagnostics based on its proprietary Affimer® and pre|CISION™...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics